---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-26-000882"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2026-06-29T20:05:29+00:00"
generated_at: "2026-06-29T20:07:42.309700+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Immunic shareholders approve 6M share increase to equity plan, elect directors, ratify auditor

## Summary
- Amendment to 2019 Omnibus Equity Plan approved, increasing authorized shares by 6,000,000 to total 8,644,887.
- Michael Bonney, Thorvald Nagel, and Richard Rudick elected as Class III directors to serve until 2029.
- Baker Tilly US, LLP ratified as independent registered public accounting firm for fiscal year 2026.
- Plan amendment vote: 4,391,782 for, 1,361,843 against, 24,538 abstain, and 3,107,100 broker non-votes.

## SEC filing metadata
- accession: 0001193805-26-000882
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2026-06-29T20:05:29+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000882/0001193805-26-000882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000882/e665616_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-26-000882
- JSON: https://secwatch.observer/filing/0001193805-26-000882.json
- Plain text: https://secwatch.observer/filing/0001193805-26-000882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.